- Home
- MGRM
as 11-14-2024 4:00pm EST
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
Upcoming Earnings Alert:
Get ready for potential market movements as Monogram Orthopaedics Inc. MGRM prepares to release earnings report on 19 Nov 2024.
| Founded: | 2016 | Country: | United States |
| Employees: | N/A | City: | BROOKLYN |
| Market Cap: | 73.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 116.7K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.38 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.53 - $4.90 | Next Earning Date: | 11-19-2024 |
| Revenue: | $364,999 | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Monogram Orthopaedics Inc. News
MGRM Breaking Stock News: Dive into MGRM Ticker-Specific Updates for Smart Investing
ACCESSWIRE
3 days ago
Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
Zacks Small Cap Research
15 days ago
MGRM: Monogram Announces it has Received an Additional Information Request (AIR) from the FDA Regarding its Recent 510(k) Submission.
ACCESSWIRE
17 days ago
Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
ACCESSWIRE
a month ago
Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
ACCESSWIRE
a month ago
CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
ACCESSWIRE
a month ago
Monogram Technologies Receives FDA Response for mBôs TKA System
ACCESSWIRE
a month ago
Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
ACCESSWIRE
a month ago
Monogram Technologies Announces Preferred Stock Dividends
Compare MGRM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGRM Monogram Orthopaedics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.